<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02509078</url>
  </required_header>
  <id_info>
    <org_study_id>PETAL01ROSE</org_study_id>
    <secondary_id>1U01HL123009-01</secondary_id>
    <nct_id>NCT02509078</nct_id>
  </id_info>
  <brief_title>Reevaluation Of Systemic Early Neuromuscular Blockade</brief_title>
  <acronym>ROSE</acronym>
  <official_title>Reevaluation Of Systemic Early Neuromuscular Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates whether giving a neuromuscular blocker (skeletal muscle relaxant) to a
      patient with acute respiratory distress syndrome will improve survival. Half of the patients
      will receive a neuromuscular blocker for two days and in the other half the use of
      neuromuscular blockers will be discouraged .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE::

      To assess the efficacy and safety of early neuromuscular blockade in reducing mortality and
      morbidity in patients with moderate-severe ARDS, in comparison to a control group with no
      routine early neuromuscular blockade (NMB).

      PRIMARY HYPOTHESIS:

      Early neuromuscular blockade will improve mortality prior to discharge home before day 90, in
      patients with moderate-severe ARDS.

      The trial will accrue a maximum of 1408 patients. Patients will be recruited from the
      emergency departments, intensive care units and other acute care areas of the PETAL Network
      Clinical Centers and randomized to the active (NMB) or control. The overall strategy is to
      screen, consent, and enroll early, every newly intubated, acutely ill or post-operative,
      eligible patient at each site, using clinically obtained pulse oximetry and blood gases.

      By preventing active expiration, and/or patient ventilator dyssynchrony, neuromuscular
      blockade may create a more homogenous distribution of airway pressures and tidal volumes,
      preventing barotrauma/volutrauma and &quot;atelectrauma&quot; resulting in less ventilator-induced lung
      injury.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 4, 2016</start_date>
  <completion_date type="Anticipated">April 4, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 4, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital Mortality to day 90</measure>
    <time_frame>90 days after randomization</time_frame>
    <description>The percentage of subjects alive at study day 90. Those subjects discharged home prior to day 90 were counted as alive at day 90.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Ventilator Free Days to day 28</measure>
    <time_frame>28 days after randomization</time_frame>
    <description>Ventilator-free days is defined to be 28 days minus the duration of mechanical ventilation through day 28. Participants who do not survive to day 28 are assigned zero ventilator-free days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Organ Failure Free days to day 28</measure>
    <time_frame>28 days after randomization</time_frame>
    <description>A patient will be considered failure free on each day alive with SOFA scores for all organ systems below 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU Free Days to day 28</measure>
    <time_frame>28 days after randomization</time_frame>
    <description>ICU free days is defined as the number of days between randomization and day 28 in which the patient is in the ICU (for any part of a day).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Hospital Free Days to days 28</measure>
    <time_frame>28 days after randomization</time_frame>
    <description>Hospital free days are days alive post hospital discharge through day 28. Patients who die on or prior to day 28 are assigned zero hopsital free days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Katz Activities of Daily Living (ADL)/Lawton Instrumental Activities Of Daily Living Scale (IADL)</measure>
    <time_frame>12 months after randomization</time_frame>
    <description>Assesses whether individual can living independantly</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQol (EQ-5D-5L): Health Related Quality of Life</measure>
    <time_frame>12 months after randomization</time_frame>
    <description>Using a standardized scale, do health reasons limit the person's ability to enjoy their life?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTSS-14: Post-traumatic Stress-like Symptoms</measure>
    <time_frame>12 months after randomization</time_frame>
    <description>Does the patient have symptoms of anxiety and stress from their ICU stay?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MoCA-Blind: Montreal Cognitive Assessment</measure>
    <time_frame>12 months after randomization</time_frame>
    <description>How clearly can patient think and recall things?</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1006</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Early Neuromuscular Blockade (NMB)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive cisastracurium besylate for the first 48 hours of the trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control: No Routine Early NMB</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Use of non-study NMB will be discouraged.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cisastracurium besylate</intervention_name>
    <description>Patients randomized to the early neuromuscular blockade arm will receive a cisastracurium besylate bolus of 15 mg, followed by a continuous infusion of 37.5 mg/hour for 48 hours. Patients randomized to the control arm will receive no protocol specified neuromuscular blockade.</description>
    <arm_group_label>Early Neuromuscular Blockade (NMB)</arm_group_label>
    <other_name>Nimbex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Age &gt; 18 years

          2. Presence of all of the following conditions for &lt; 48 hours:

             i. PaO2/FiO2 &lt; 150 with PEEP &gt;/= 8 cm H2O OR, if ABG not available, SaO2/FiO2 ratio
             that is equivalent to a PaO2/FiO2 &lt; 150 with PEEP &gt;/= 8 cm H2O , and a confirmatory
             SaO2/FiO2 ratio that is again equivalent 1-6 hours later

        ii. Bilateral opacities not fully explained by effusions, lobar/lung collapse, or nodules.

        iii. Respiratory failure not fully explained by cardiac failure or fluid overload; need
        objective assessment (e.g., echocardiography) to exclude hydrostatic edema if no risk
        factor present.

        Patients must be enrolled within 48 hours of meeting inclusion criteria.

        Exclusion Criteria:

          1. Lack of informed consent

          2. Continuous neuromuscular blockade at enrollment

          3. Known pregnancy

          4. Currently receiving ECMO therapy

          5. Chronic respiratory failure defined as PaCO2 &gt; 60 mm Hg in the outpatient setting

          6. Home mechanical ventilation (non-invasive ventilation or via tracheotomy) except for
             CPAP/BIPAP used solely for sleep-disordered breathing

          7. Actual body weight exceeding 1 kg per centimeter of height

          8. Severe chronic liver disease defined as a Child-Pugh score of 12-15 (Appendix A2)

          9. Bone marrow transplantation within the last 1 year

         10. Expected duration of mechanical ventilation of &lt; 48 hours

         11. Decision to withhold life-sustaining treatment; except in those patients committed to
             full support except cardiopulmonary resuscitation if an actual cardiac arrest occurs

         12. Moribund patient not expected to survive 24 hours; if CPR provided, assess for
             moribund status greater than 6 from CPR conclusion

         13. Diffuse alveolar hemorrhage from vasculitis

         14. Burns &gt; 70% total body surface

         15. Unwillingness to utilize the ARDS Network 6 ml/kg IBW ventilation protocol

         16. Previous hypersensitivity or anaphylactic reaction to cisatracurium

         17. Neuromuscular conditions that may potentiate neuromuscular blockade and/or impair
             spontaneous ventilation (Appendix A2)

         18. Neurologic conditions undergoing treatment for intracranial hypertension

         19. Enrollment in an interventional ARDS trial with direct impact on neuromuscular
             blockade and PEEP

         20. &gt;120 hours of mechanical ventilation

         21. P/F &lt; 200 mmHg at the time of randomization (if available)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David A. Schoenfeld, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF Fresno</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ronald Reagan UCLA Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Hospital</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center of Aurora</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Denver Health Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University Methodist Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Medical Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mt. Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wesley Long Hospital</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Summa Akron City Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC Presbyterian/Mercy/Shadyside</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15261</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McKay-Dee Hospital</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Utah Valley Regional Medical Center</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LDS Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University or Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VCU Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Hospital Cherry Hill</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Hospital First Hill</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://petalnet.org</url>
    <description>Website for the PETAL Network</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2015</study_first_submitted>
  <study_first_submitted_qc>July 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2015</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>David Alan Schoenfeld</investigator_full_name>
    <investigator_title>Prinicipal Investigator PETAL CCC</investigator_title>
  </responsible_party>
  <keyword>ARDS</keyword>
  <keyword>neuromuscular blocker</keyword>
  <keyword>cisatracurium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be collected electronically and stored at the Clinical Coordinating Center at MGH. A de-identified database of all data will be available for use 3 years after the primary publication. Data can be accessed at that point via the NHLBI BioLINCC data repository.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

